Success Metrics

Clinical Success Rate
87.5%

Based on 21 completed trials

Completion Rate
88%(21/24)
Active Trials
2(7%)
Results Posted
33%(7 trials)
Terminated
3(11%)

Phase Distribution

Ph phase_4
6
21%
Ph phase_3
13
46%
Ph phase_1
2
7%
Ph phase_2
6
21%

Phase Distribution

2

Early Stage

6

Mid Stage

19

Late Stage

Phase Distribution27 total trials
Phase 1Safety & dosage
2(7.4%)
Phase 2Efficacy & side effects
6(22.2%)
Phase 3Large-scale testing
13(48.1%)
Phase 4Post-market surveillance
6(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.0%

21 of 25 finished

Non-Completion Rate

16.0%

4 ended early

Currently Active

2

trials recruiting

Total Trials

28

all time

Status Distribution
Active(2)
Completed(21)
Terminated(4)
Other(1)

Detailed Status

Completed21
Terminated3
Withdrawn1
Recruiting1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
2
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (7.4%)
Phase 26 (22.2%)
Phase 313 (48.1%)
Phase 46 (22.2%)

Trials by Status

withdrawn14%
recruiting14%
completed2175%
active_not_recruiting14%
terminated311%
unknown14%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT01628029Phase 2

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Active Not Recruiting
NCT05185583Phase 2

Methylphenidate in Childhood Apraxia of Speech

Completed
NCT06465641Phase 4

Methylphenidate in KBG Syndrome: N-of-1 Series

Recruiting
NCT00003266Phase 3

Methylphenidate in Treating Patients With Melanoma

Completed
NCT04968522Phase 4

FASST - Fetal Alcohol Spectrum Stimulant Trial

Unknown
NCT04152629Phase 4

Real World Evidence of the Efficacy and Safety of FOQUEST

Completed
NCT00031798Phase 3

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Terminated
NCT00763971Phase 3

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17

Completed
NCT01552902Phase 4

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Completed
NCT01183234Phase 1

SPD544 High Strength Bioequivalence Study

Completed
NCT01552915Phase 4

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Completed
NCT02247986Phase 1

Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder

Withdrawn
NCT01914822Phase 2

The Effect Methylphenidate Hydrochloride on Pain and Auditory Sensitivity in Healthy Subjects

Completed
NCT00376675Phase 3

Methylphenidate in Treating Patients With Fatigue Caused by Cancer

Completed
NCT01624649

A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

Completed
NCT00593853Phase 2

Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy

Terminated
NCT01348607Phase 2

Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy

Terminated
NCT00302393Phase 3

Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults

Completed
NCT00302406Phase 4

Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate

Completed
NCT00301639Phase 3

A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults

Completed

Drug Details

Intervention Type
DRUG
Total Trials
28